Masimo Corp. (MASI)

153.60
3.34 2.22
NASDAQ : Health Technology
Prev Close 150.26
Open 149.89
Day Low/High 149.32 / 153.86
52 Wk Low/High 98.23 / 160.25
Volume 327.87K
Avg Volume 348.00K
Exchange NASDAQ
Shares Outstanding 53.33M
Market Cap 8.02B
EPS 3.70
P/E Ratio 42.66
Div & Yield N.A. (N.A)

Latest News

Root® With Pathway™ (Photo: Business Wire)

Root® With Pathway™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) today announced Pathway™, a feature for the Root ® Patient Monitoring and Connectivity Platform.

Masimo Root® And Radical-7® With ORi™ (Photo: Business Wire)

Masimo Root® And Radical-7® With ORi™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that in a randomized controlled study involving 150 ICU patients recently published as a letter in Intensive Care Medicine, researchers investigated whether monitoring with Masimo ORi™ (Oxygen Reserve Index) could...

Masimo Announces Investment In Pulmonary Care Company TNI Medical AG

Masimo Announces Investment In Pulmonary Care Company TNI Medical AG

Masimo (NASDAQ: MASI), a global leader in innovative noninvasive monitoring technologies, today announced it has closed on a strategic investment with TNI medical AG ("TNI"), a privately held, commercial-stage medical device company headquartered in...

Masimo Root® With SpHb® And PVi® (Photo: Business Wire)

Masimo Root® With SpHb® And PVi® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that in a study published in the Journal of Clinical Monitoring and Computing, researchers investigated the effects of implementing a hospital-wide fluid and blood administration protocol using two Masimo...

Masimo Root® With SpHb® And PVi® (Photo: Business Wire)

Masimo Root® With SpHb® And PVi® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the CE marking of SpHb ®, noninvasive and continuous hemoglobin monitoring, for neonatal and infant patients (3 kg but is not currently indicated for patients <3 kg in the US.

Masimo Reports Second Quarter 2019 Financial Results

Masimo Reports Second Quarter 2019 Financial Results

Masimo (NASDAQ: MASI) today announced its financial results for the second quarter ended June 29, 2019.

Masimo Root&reg; With SpHb&reg; And PVi&reg; (Photo: Business Wire)

Masimo Root® With SpHb® And PVi® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that in a study recently published in Anesthesia & Analgesia, researchers evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb ® to detect the development of acute hemodilution...

Masimo To Report Second Quarter 2019 Financial Results After Market Close On Wednesday, July 31

Masimo To Report Second Quarter 2019 Financial Results After Market Close On Wednesday, July 31

Masimo (NASDAQ: MASI) announced today that it will release second quarter 2019 financial results for the period ended June 29, 2019, after the market closes on Wednesday, July 31, 2019.

Masimo Root&reg; With Radical-7&reg; And ORi&trade; (Photo: Business Wire)

Masimo Root® With Radical-7® And ORi™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers investigated the ability of Masimo ORi™ (Oxygen Reserve Index) to serve as a noninvasive indicator of the arterial...

Masimo Root&reg; With SedLine&reg; (Photo: Business Wire)

Masimo Root® With SedLine® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that in a study recently published in Anesthesia & Analgesia, researchers investigated the incidence of isoelectric electroencephalogram (EEG) events in infants and young children undergoing scheduled surgery...

Masimo Root&reg; With O3&reg; Regional Oximetry (Photo: Business Wire)

Masimo Root® With O3® Regional Oximetry (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that O3 ® Regional Oximetry has received FDA clearance for use on neonatal and infant patients (<10 kg).

Masimo Root&reg; Patient Monitoring And Connectivity Platform (Photo: Business Wire)

Masimo Root® Patient Monitoring And Connectivity Platform (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that NuVision Management Healthcare Consulting Company, a pediatric and adult healthcare consulting company, is adopting a comprehensive variety of Masimo technologies at its three pediatric care facilities in New...

Masimo Radical-7&reg; With SpHb&reg; (Photo: Business Wire)

Masimo Radical-7® With SpHb® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the results of a study published in BMC Anesthesiology in which clinicians at Peking Union Medical College in Beijing evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb ® to...

Masimo Hosts 2019 Investor Day

Masimo Hosts 2019 Investor Day

Masimo (NASDAQ: MASI) is hosting an Investor Day at its headquarters in Irvine today, which will include presentations by Chairman and Chief Executive Officer Joe Kiani and other members of the executive team.

Masimo Radius PPG&trade; (Photo: Business Wire)

Masimo Radius PPG™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today FDA 510(k) clearance of Radius PPG, a tetherless sensor solution powered by Masimo SET ® that represents a significant breakthrough in patient monitoring.

Masimo To Present At UBS Global Healthcare Conference

Masimo To Present At UBS Global Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the UBS Global Healthcare Conference at the Grand Hyatt New York on Tuesday, May 21, 2019 at 2:00 p.

Masimo And Mindray Announce Expanded Partnership

Masimo And Mindray Announce Expanded Partnership

Masimo (NASDAQ: MASI) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Masimo Reports First Quarter 2019 Financial Results

Masimo Reports First Quarter 2019 Financial Results

Masimo (Nasdaq: MASI) today announced its financial results for the first quarter ended March 30, 2019.

Notable Monday Option Activity: MASI, TACO, TOCA

Notable Monday Option Activity: MASI, TACO, TOCA

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Masimo Corp. , where a total volume of 2,548 contracts has been traded thus far today, a contract volume which is representative of approximately 254,800 underlying shares (given that every 1 contract represents 100 underlying shares).

Masimo Patient SafetyNet&trade; With Halo ION&trade; (Photo: Business Wire)

Masimo Patient SafetyNet™ With Halo ION™ (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today that after a decade of developing and testing its comprehensive, scalable, and customizable continuous early warning score, with the aid of leading expert clinicians around the world, it is releasing Halo ION™.

Masimo Root&reg; With Next Generation SedLine&reg; Brain Function Monitoring And Mdoloris ANI&reg; (Photo: Business Wire)

Masimo Root® With Next Generation SedLine® Brain Function Monitoring And Mdoloris ANI® (Photo: Business Wire)

Masimo (NASDAQ: MASI) and Mdoloris Medical Systems announced today the CE marking of the Mdoloris Analgesia Nociception Index (ANI ®) module for the Masimo Root ® Patient Monitoring and Connectivity Hub, the first commercially available result of a Masimo...

Masimo To Report First Quarter 2019 Financial Results After Market Close On Monday, May 6

Masimo To Report First Quarter 2019 Financial Results After Market Close On Monday, May 6

Masimo (NASDAQ: MASI) announced today that it will release first quarter 2019 financial results for the period ended March 30, 2019, after the market closes on Monday, May 6, 2019.

Masimo Root&reg; With O3&reg; Regional Oximetry And Next Generation SedLine&reg; Brain Function Monitoring (Graphic: Business Wire)

Masimo Root® With O3® Regional Oximetry And Next Generation SedLine® Brain Function Monitoring (Graphic: Business Wire)

Masimo (NASDAQ: MASI) announced today the findings of a study, recently published in Anaesthesia and Intensive Care, in which researchers at Austin Hospital in Melbourne, Australia sought to measure cerebral oxygenation in a large cohort of healthy...

Masimo To Present At 18th Annual Needham Healthcare Conference

Masimo To Present At 18th Annual Needham Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 18th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York on Tuesday, April 9, 2019 at 12:50 p.

Masimo Rad-67&trade; Pulse CO-Oximeter&reg; (Photo: Business Wire)

Masimo Rad-67™ Pulse CO-Oximeter® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today FDA clearance of the Rad-67™ Pulse CO-Oximeter ® with Spot-check Next Generation SpHb ® monitoring technology and the rainbow ® DCI ®-mini Reusable Sensor.

Masimo To Present At Barclays Global Healthcare Conference

Masimo To Present At Barclays Global Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel on Wednesday, March 13, 2019 at 4:50 p.

Masimo Root&reg; With Next Generation SedLine&reg; (Photo: Business Wire)

Masimo Root® With Next Generation SedLine® (Photo: Business Wire)

Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine ® brain function monitoring for pediatric patients (1-18 years of age).

TheStreet Quant Rating: B+ (Buy)